| Biotechnology Industry | Healthcare Sector | Mr. Xiaoliang Fang CEO | SSE Exchange | CNE100003RM8 ISIN |
| CN Country | 2,231 Employees | 26 Jun 2023 Last Dividend | 26 Jun 2023 Last Split | - IPO Date |
Zhejiang Orient Gene Biotech Co., Ltd., established in 2005 and headquartered in Huzhou, China, is a prestigious enterprise in the biotechnology industry specializing in the research, development, production, and distribution of in vitro diagnostic products on a global scale. The company is recognized for its comprehensive range of diagnostic solutions catering to various healthcare needs, including infectious diseases, drug testing, and fertility assessments.
Zhejiang Orient Gene Biotech offers a wide array of diagnostic products and services, segmented into distinct categories to meet diverse market demands: